Discover the top abstracts of note for the 2023 ASH annual meeting.Read More
Cleveland Clinic is the first to create a multidisciplinary clinic to triage and care for patients with immune-related adverse events.
Researchers strive to find optimal approach for reducing toxicities resulting from graft-versus-host-disease prophylaxis treatment.
Research study aims to identify biomarkers for predicting response to prostate cancer treatment.
Palliative medicine physician David Harris, MD, discusses best practices and recent advances in managing gastrointestinal symptoms in patients with cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Use of low-dose radiation a non-invasive treatment for certain types of osteoarthritis
Research team found ultra-hypofractionated radiotherapy improved on the current standard of care for treating soft tissue sarcoma.
Breast Surgery Specialist Stephanie Valente, DO, discusses the diagnosis and treatment of Paget’s disease, a rare form of ductal carcinoma in situ that may look like eczema or psoriasis of the nipple and areola.
Cleveland Clinic’s Director of Rare Cancers and Blood Diseases explains how having a formalized system in place for treating rare cancers can shorten the diagnostic odyssey and help improve patient outcomes and quality of life.
Researchers delve into the origins of drug resistance in small cell lung cancer.
New study yields clues to the cause of relapse after bone marrow transplant in patients with certain types of leukemia.